| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥36663.3B | ¥35932.2B | +2.0% |
| Operating Income | ¥3079.1B | ¥3187.4B | -3.4% |
| Ordinary Income | ¥3056.7B | ¥2924.8B | +4.5% |
| Net Income | ¥2042.2B | ¥1952.7B | +4.6% |
| ROE | 6.3% | 6.8% | - |
FY2025 Q3 cumulative results showed revenue of 3,666.3 billion yen (YoY +2.0%), operating income of 307.9 billion yen (YoY -3.4%), ordinary income of 305.7 billion yen (YoY +4.5%), and net income of 204.2 billion yen (YoY +4.6%). Revenue growth remained modest while operating income declined, primarily due to cost pressures and product quality expenses. The gap between operating income decline and ordinary income increase reflects improved non-operating results. Operating margin compressed to 8.4% from the prior year's 8.9%, indicating profitability challenges despite top-line expansion. Strong cash generation with operating cash flow of 345.7 billion yen exceeded net income by 1.77x, though working capital efficiency deteriorated with extended inventory and receivables cycles.
Revenue increased 2.0% YoY to 3,666.3 billion yen, driven primarily by the Air Conditioning and Refrigeration Equipment segment which grew 2.0% to 3,403.1 billion yen, while the Chemicals segment expanded 13.2% to 213.1 billion yen. Geographically, the United States led with 1,320.8 billion yen (+6.0% YoY), followed by Europe at 593.9 billion yen (+6.2% YoY) and Japan at 591.5 billion yen (+3.9% YoY). China declined 7.4% to 384.7 billion yen, reflecting softer demand in that market. Asia-Oceania decreased 5.8% to 502.6 billion yen. Other regions increased 2.2% to 272.7 billion yen. The modest overall revenue growth reflects mixed regional performance with strength in developed markets offset by weakness in China.
Operating income decreased 3.4% YoY to 307.9 billion yen despite revenue growth, indicating margin compression. Selling, general and administrative expenses of 967.3 billion yen represented a significant cost burden. Product warranty provisions of 129.2 billion yen (approximately 3.5% of revenue) remained elevated, signaling ongoing quality cost pressures. The Air Conditioning and Refrigeration Equipment segment generated operating income of 28.8 billion yen (operating margin 8.5%), while Chemicals contributed 1.8 billion yen (margin 8.5%). The decline in operating profit despite revenue growth suggests unfavorable product mix, increased operational costs, and quality-related expenses.
Ordinary income improved 4.5% to 305.7 billion yen, recovering from the operating income decline through better non-operating results. Non-operating income totaled 35.1 billion yen, including interest income of 13.8 billion yen and dividend income of 4.1 billion yen. Non-operating expenses were 37.3 billion yen, including foreign exchange losses of 1.3 billion yen. The net non-operating impact of negative 2.2 billion yen was less unfavorable than the prior year, contributing to the ordinary income recovery. Net income rose 4.6% to 204.2 billion yen, supported by the ordinary income improvement and effective tax management.
This represents a revenue up, profit down pattern at the operating level, transitioning to revenue up, profit up when considering ordinary and net income. The divergence highlights the importance of non-operating factors in offsetting operational margin pressures.
The Air Conditioning and Refrigeration Equipment segment is the core business, accounting for 92.8% of total revenue with 3,403.1 billion yen in sales and 28.8 billion yen in operating income. Revenue increased 2.0% YoY while operating income grew 1.4%, resulting in an operating margin of 8.5%. This segment demonstrated resilience with balanced growth across most regions except China, where the 8.2% sales decline to 335.3 billion yen weighed on overall performance.
The Chemicals segment contributed 5.8% of revenue with 213.1 billion yen in sales and 1.8 billion yen in operating income. Revenue surged 13.2% YoY but operating income declined significantly by 44.6%, compressing the operating margin to 8.5% from 15.6% in the prior year. This sharp margin deterioration suggests pricing pressures, raw material cost inflation, or product mix challenges within the chemicals business.
Other segments (including oil equipment, special equipment, and electronic systems) generated 72.8 billion yen in revenue with operating income of 1.6 billion yen. Both segments maintained similar operating margins around 8.5%, but the Chemicals segment's profitability decline stands out as a key area requiring management attention. The Air Conditioning and Refrigeration Equipment segment's stable margin performance supports overall business resilience despite volume challenges in certain markets.
[Profitability] ROE of 6.1% remains below the industry median of 5.0% for manufacturing but indicates room for improvement relative to the company's asset base and leverage. Operating margin of 8.4% aligns with the industry median of 8.3%, though it declined from 8.9% in the prior year. Net profit margin of 5.3% falls below the industry median of 6.3%, reflecting cost pressures and below-average profit conversion. Gross profit margin of 34.8% and EBITDA margin of 12.9% demonstrate solid fundamental profitability, but the gap to operating margin highlights significant SG&A burden. [Cash Quality] Cash and deposits of 985.7 billion yen provide strong liquidity with cash coverage of short-term debt at 3.63x. Operating cash flow of 345.7 billion yen represents 1.77x net income, confirming high-quality cash-backed earnings. However, working capital efficiency deteriorated with days sales outstanding of 81 days (near industry median of 83 days), days inventory outstanding of 122 days (above industry median of 109 days), and days payables outstanding of 0 days yielding a cash conversion cycle of 204 days. [Investment Efficiency] Asset turnover of 0.65 exceeds the industry median of 0.58, indicating relatively efficient asset utilization. Return on assets of 3.6% slightly exceeds the industry median of 3.3%. Return on invested capital of 6.5% surpasses the industry median of 5.0%, demonstrating effective capital deployment. CapEx to depreciation ratio of 0.89 falls below the industry median of 1.44, suggesting conservative capital investment relative to asset renewal needs. [Financial Health] Equity ratio of 56.7% compares favorably to the industry median of 63.8%, indicating moderate leverage. Current ratio of 195.1% is well below the industry median of 284%, but still provides adequate short-term liquidity. Financial leverage of 1.76x sits above the industry median of 1.53x, reflecting a slightly more leveraged capital structure. Debt-to-EBITDA of 1.13x indicates manageable debt burden with comfortable coverage, supported by interest coverage of 16.06x.
Operating cash flow of 345.7 billion yen represents 1.77x net income of 204.2 billion yen, confirming strong cash generation and high-quality earnings. The cash conversion ratio of 0.73 (operating CF to EBITDA) falls below the industry median of 1.24, primarily due to working capital increases. Inventory increased to 800.6 billion yen with days inventory outstanding of 122 days exceeding the industry median of 109 days, indicating inventory buildup that absorbed cash. Accounts receivable of 809.5 billion yen with days sales outstanding of 81 days tracks near the industry median of 83 days, though the absolute level represents a significant working capital investment. Investing cash flow of 294.6 billion yen was primarily driven by capital expenditures of 144.6 billion yen, representing 0.89x depreciation and indicating disciplined investment. Free cash flow of 51.0 billion yen (operating CF minus investing CF) provides modest financial flexibility. Financing cash flow details indicate dividend payments absorbed a portion of available cash. Cash and deposits increased from prior periods to 985.7 billion yen, providing a strong liquidity cushion. The combination of robust operating cash generation and conservative CapEx supports sustainable dividend payments, though the FCF coverage ratio of 0.53 suggests limited surplus after dividends and capital investment. Working capital management warrants attention as elevated inventory and receivables levels constrain cash conversion efficiency below industry peers.
Ordinary income of 305.7 billion yen versus operating income of 307.9 billion yen shows a modest negative non-operating contribution of 2.2 billion yen. Non-operating income of 35.1 billion yen included interest income of 13.8 billion yen and dividend income of 4.1 billion yen as primary components. Non-operating expenses of 37.3 billion yen included foreign exchange losses of 1.3 billion yen. Non-operating items represent less than 1% of revenue, indicating that core operating performance drives earnings. Operating cash flow of 345.7 billion yen exceeds net income of 204.2 billion yen, yielding an accrual ratio of negative 2.6%, which indicates earnings are conservatively stated and not inflated by aggressive accruals. This negative accrual ratio combined with strong cash generation suggests high-quality earnings. However, the elevated product warranty provision of 129.2 billion yen (3.5% of revenue) represents a significant quality cost that warrants monitoring. The warranty ratio exceeds typical manufacturing benchmarks, suggesting either product quality challenges or conservative provisioning. The cash conversion cycle of 204 days, driven by inventory days of 122 and receivables days of 81, indicates working capital is a drag on cash realization despite strong reported earnings. Overall earnings quality is supported by strong cash generation and conservative accruals, but operational efficiency metrics and quality costs present areas for improvement.
Full-year guidance projects revenue of 4,920.0 billion yen (+3.5% YoY), operating income of 413.0 billion yen (+2.8% YoY), ordinary income of 398.0 billion yen (+8.6% YoY), and net income of 268.0 billion yen. Q3 cumulative progress rates stand at 74.5% for revenue, 74.6% for operating income, 76.8% for ordinary income, and 76.2% for net income, all tracking ahead of the standard 75% benchmark for nine-month results. Revenue progress is slightly below target, suggesting Q4 will require stronger momentum to achieve the full-year target. Operating income progress aligns with expectations, while ordinary income and net income are tracking slightly ahead of plan. The guidance implies Q4 operating income must reach approximately 105.1 billion yen to meet the full-year target of 413.0 billion yen, which would represent a sequential improvement from Q3 run rates. Key assumptions likely include stable foreign exchange rates, continued strength in developed markets, and stabilization in China demand. The projected acceleration in ordinary income growth to 8.6% versus operating income growth of 2.8% suggests expectations for improved non-operating results or one-time gains. Given the Q3 cumulative performance, the full-year targets appear achievable but require disciplined cost management and maintained sales momentum through year-end.
The company paid an interim dividend of 185 yen per share in Q2 and has announced an expected year-end dividend of 145 yen per share, implying a total annual dividend of 165 yen per share based on full-year guidance. This represents a modest increase from prior dividend levels, reflecting management's confidence in cash generation. The payout ratio based on full-year guidance of 268.0 billion yen net income and 165 yen per share dividend calculates to approximately 49.5%, which is elevated for a manufacturing company but within sustainable range given the strong cash generation profile. Free cash flow of 51.0 billion yen provides an FCF coverage ratio of 0.53 for dividends plus CapEx, indicating that current dividend levels consume a meaningful portion of available cash after investment needs. However, operating cash flow of 345.7 billion yen provides ample coverage of the dividend obligation. The payout ratio of 49.5% suggests a balanced approach to capital allocation, returning roughly half of earnings to shareholders while retaining the remainder for reinvestment and balance sheet flexibility. No share buyback activity was disclosed in the available data. The total shareholder return policy appears focused on stable and growing dividends supported by operating cash generation, though the limited FCF surplus constrains flexibility for significant payout increases or additional buybacks without improvements in working capital efficiency or capital expenditure optimization.
Product quality risk remains elevated with warranty provisions of 129.2 billion yen representing 3.5% of revenue, substantially above typical manufacturing norms. This indicates ongoing quality challenges or exposure to warranty claims that could escalate if product performance issues persist or expand. Working capital efficiency deterioration poses cash flow risk, with inventory days of 122 exceeding industry median of 109 days and the cash conversion cycle of 204 days tying up significant capital. Continued inventory buildup or receivables extension would further constrain cash generation and financial flexibility. Geographic concentration risk is material with the China market declining 7.4% YoY to 384.7 billion yen, representing 10.5% of total revenue. Further deterioration in China demand amid macroeconomic challenges or geopolitical tensions could significantly impact consolidated results and profitability.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE of 6.1% exceeds the manufacturing industry median of 5.0%, indicating above-median equity returns despite operational challenges. Operating margin of 8.4% aligns precisely with the industry median of 8.3%, positioning the company at the center of the profitability distribution. Net profit margin of 5.3% falls below the industry median of 6.3%, suggesting below-average profit conversion efficiency relative to manufacturing peers.
Financial Health: Equity ratio of 56.7% is below the industry median of 63.8%, reflecting a more leveraged capital structure with financial leverage of 1.76x versus the industry median of 1.53x. Current ratio of 195.1% substantially trails the industry median of 284.0%, though absolute liquidity remains adequate. Net debt to EBITDA of 1.13x compares favorably to the industry median of negative 1.11x (indicating net cash positions are common), but remains within manageable ranges.
Efficiency: Asset turnover of 0.65 exceeds the industry median of 0.58, demonstrating superior asset utilization efficiency. Inventory turnover of 122 days exceeds the industry median of 109 days, indicating slower inventory movement and higher working capital requirements. Receivables turnover of 81 days aligns closely with the industry median of 83 days, showing typical collection efficiency.
Growth: Revenue growth of 2.0% YoY is below the industry median of 2.7%, positioning the company in the lower half of growth rates within manufacturing. EPS growth progress reflects the modest profitability expansion relative to peer benchmarks.
Overall, the company demonstrates above-median asset efficiency and equity returns but faces challenges in profit conversion, working capital management, and growth momentum relative to industry peers. The financial structure is more leveraged than typical manufacturing peers but remains within sustainable parameters.
※ Industry: Manufacturing (98 companies), Comparison: FY2025 Q3, Source: Proprietary analysis
Cash generation quality remains a core strength with operating cash flow of 345.7 billion yen exceeding net income by 1.77x and strong interest coverage of 16.06x, indicating the business consistently converts earnings to cash despite working capital headwinds. This provides a solid foundation for sustained dividend payments and financial stability.
Working capital efficiency deterioration represents the primary operational concern, with inventory days of 122 and cash conversion cycle of 204 days both exceeding industry medians. The inventory buildup and extended working capital cycle absorbed significant cash during the period, constraining free cash flow to 51.0 billion yen. Management focus on inventory optimization and receivables collection could unlock substantial cash and improve returns on invested capital.
Geographic mix shifts present both opportunity and risk, with developed markets (US +6.0%, Europe +6.2%) demonstrating growth resilience while China declined 7.4%. The company's ability to sustain momentum in western markets while navigating China challenges will determine whether revenue growth can accelerate toward mid-single digits and support operating leverage recovery from the current 8.4% margin that has compressed from prior periods.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.